Physician profile
Leila Saeed
NPI 1265049597
$750.11
in general payments reported to CMS, 2019-2025
11 companies · $547 in 2025
The $547 reported for 2025 was more than what 91% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.26 · 2022: $12.27 · 2023: $86.54 · 2024: $65.55 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $375 · Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $374.75 |
| Food and Beverage | $324.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Colgate Oral Pharmaceuticals, INC. | $374.75 | 2025 | |
| Dentsply Sirona INC | $101.01 | 2025 | Astra Tech Implant System |
| Orapharma, A Division of Bausch Health US, LLC | $68.42 | 2021-2025 | Arestin |
| Philips North America LLC | $64.61 | 2021-2025 | (E55) Oral Health Care Und, Oral Health Care Undivided |
| Nobel Biocare USA | $32.64 | 2023 | Nobelactive |
| Zest Holdings, LLC | $28.57 | 2024 | |
| Envista Holdings Corporation | $19.72 | 2025 | Harmonize |
| Ormco Corporation | $19.24 | 2023 | Legacy System |
| Solventum Corporation | $18.56 | 2024 | Filtek, Vanish, 3m Scotchbond |
| Kerr Corporation | $12.27 | 2022 | |
| Align Technology, INC. | $10.32 | 2025 | Invisalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leila Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.